We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
EPAM Systems
EPAM
$5.17B
| $5.03M | 0.01% |
29,777
+2,134
| +8% | +$471K |
|
802
Crown Holdings
CCK
$13.1B
| $5.02M | 0.01% |
56,290
-2,305
| -4% | -$201K |
|
803
Carlyle Group
CG
$17.2B
| $5.02M | 0.01% |
115,191
+5,141
| +5% | +$255K |
|
804
NetEase
NTES
$79.5B
| $4.91M | 0.01% |
47,738
-86,375
| -64% | -$8.68M |
|
805
XP
XP
$7.98B
| $4.84M | 0.01% |
352,295
-7,345
| -2% | -$101K |
|
806
Eastman Chemical
EMN
$8.29B
| $4.84M | 0.01% |
54,971
-8,007
| -13% | -$756K |
|
807
BioCryst Pharmaceuticals
BCRX
$2.71B
| $4.8M | 0.01% |
612,324
+585,882
| +2,216% | +$4.73M |
|
808
HEICO Corp
HEI
$52.1B
| $4.73M | 0.01% |
17,690
-2,340
| -12% | -$570K |
|
809
Reddit
RDDT
$29.5B
| $4.71M | 0.01% |
44,865
+37,621
| +519% | +$6.22M |
|
810
Twist Bioscience
TWST
$7.85B
| $4.69M | 0.01% |
116,426
+108,295
| +1,332% | +$4.88M |
|
811
MasterBrand
MBC
$1.87B
| $4.68M | 0.01% |
358,057
+339,948
| +1,877% | +$5.17M |
|
812
BioNTech
BNTX
$23.3B
| $4.64M | 0.01% |
48,916
+4,960
| +11% | +$555K |
|
813
Ryan Specialty Holdings
RYAN
$11B
| $4.59M | 0.01% |
62,193
+46,891
| +306% | +$3.19M |
|
814
CAE Inc. Common Shares
CAE
$8.9B
| $4.51M | 0.01% |
183,322
+18,071
| +11% | +$440K |
|
815
SEI Investments
SEIC
$12.7B
| $4.49M | 0.01% |
57,780
-1,200
| -2% | -$96.5K |
|
|
JKS
816
JinkoSolar
JKS
$860M
| $4.45M | ﹤0.01% |
238,877
| – | – |
|
817
ZTO Express
ZTO
$17.6B
| $4.44M | ﹤0.01% |
+223,821
| New | +$4.37M |
|
818
Tarsus Pharmaceuticals
TARS
$3.07B
| $4.38M | ﹤0.01% |
84,697
+79,567
| +1,551% | +$3.93M |
|
819
Corebridge Financial
CRBG
$15.1B
| $4.34M | ﹤0.01% |
137,627
-27,531
| -17% | -$891K |
|
820
DaVita
DVA
$11.6B
| $4.31M | ﹤0.01% |
28,192
+354
| +1% | +$55.6K |
|
821
Textron
TXT
$15.3B
| $4.28M | ﹤0.01% |
59,188
-7,286
| -11% | -$545K |
|
822
Remitly
RELY
$5.1B
| $4.28M | ﹤0.01% |
205,591
-2,419
| -1% | -$55.5K |
|
823
Tyra Biosciences
TYRA
$1.51B
| $4.27M | ﹤0.01% |
459,113
+105,101
| +30% | +$1.36M |
|
824
Compañía de Minas Buenaventura
BVN
$8.79B
| $4.18M | ﹤0.01% |
267,675
-2,400
| -0.9% | -$32.3K |
|
825
Evergy
EVRG
$19.2B
| $4.17M | ﹤0.01% |
60,472
-6,385
| -10% | -$418K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.